HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Stephane Nancey Selected Research
Stephane Nancey Research Topics
Disease
17
Crohn Disease (Crohn's Disease)
05/2024 - 09/2010
14
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2023 - 04/2013
11
Ulcerative Colitis
12/2023 - 04/2013
4
Inflammation (Inflammations)
01/2023 - 02/2015
3
Neoplasms (Cancer)
01/2020 - 01/2016
3
Colitis
01/2017 - 11/2009
2
Hemorrhage
10/2021 - 01/2020
2
Infections
10/2018 - 11/2016
1
Overweight
12/2023
1
Obesity
12/2023
1
Fatigue
10/2023
1
IgA Vasculitis (Purpura, Schoenlein Henoch)
01/2022
1
Spontaneous Abortion (Miscarriage)
01/2021
1
Necrosis
01/2021
1
Sclerosing Cholangitis
09/2019
1
Pathologic Constriction (Stenosis)
01/2018
1
Adenocarcinoma
11/2016
1
Pulmonary Tuberculosis
11/2016
Drug/Important Bio-Agent (IBA)
10
vedolizumab
IBA
12/2022 - 11/2016
7
Ustekinumab (CNTO 1275)
FDA Link
05/2023 - 01/2020
5
Antibodies
IBA
05/2023 - 01/2017
5
Steroids
IBA
01/2023 - 11/2016
5
Leukocyte L1 Antigen Complex (Calgranulin)
IBA
09/2020 - 04/2013
4
Infliximab (Remicade)
FDA Link
01/2022 - 09/2010
2
risankizumab
IBA
05/2024 - 01/2023
2
ORALIT (ORS)
IBA
12/2023 - 10/2023
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2019 - 01/2016
2
Integrins
IBA
08/2018 - 11/2016
2
C-Reactive Protein
IBA
01/2017 - 04/2013
2
Biomarkers (Surrogate Marker)
IBA
11/2014 - 04/2013
1
tofacitinib
IBA
12/2023
1
CT-P13
IBA
01/2022
1
Tumor Necrosis Factors
IBA
06/2021
1
Calcineurin Inhibitors
IBA
01/2019
1
golimumab
FDA Link
01/2019
1
Immunosuppressive Agents (Immunosuppressants)
IBA
10/2018
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
10/2018
1
Tretinoin (Retinoic Acid)
FDA Link
Generic
08/2018
1
Monoclonal Antibodies
IBA
08/2018
1
Cell Adhesion Molecule-1
IBA
08/2018
1
Adalimumab (Humira)
FDA Link
01/2018
1
Interleukin-10 (Interleukin 10)
IBA
01/2017
1
Sodium
IBA
01/2017
1
Dextrans (Dextran)
FDA Link
01/2017
1
DNA (Deoxyribonucleic Acid)
IBA
11/2016
1
DIMS0150
IBA
11/2016
1
Toll-Like Receptor 9
IBA
11/2016
1
Tumor Necrosis Factor Inhibitors
IBA
02/2015
1
S100A12 Protein
IBA
02/2015
1
S100 Proteins (S 100 Protein)
IBA
02/2015
1
Neopterin
IBA
04/2013
1
Peptides (Polypeptides)
IBA
01/2011
1
Viral Antigens
IBA
01/2011
1
Granzymes (Granzyme)
IBA
01/2011
1
2,4-dinitrobenzene
IBA
11/2009
1
Haptens
IBA
11/2009
1
Sulfonic Acids
IBA
11/2009
Therapy/Procedure
16
Therapeutics
01/2023 - 01/2016
1
Contraindications
10/2022
1
Subcutaneous Injections
01/2022
1
Radiotherapy
01/2021
1
Duration of Therapy
07/2020
1
Lasers (Laser)
01/2019
1
Oral Administration
11/2009